CJC+IPA
Anti-Aging
CJC+IPA is a synergistic 10mg research blend combining CJC-1295 (a GHRH analog) and Ipamorelin (a selective GHRP/ghrelin receptor agonist) at 5mg each. This dual-peptide combination is studied for its complementary mechanisms in growth hormone secretion research ¡ª CJC-1295 extends the natural GH pulse while Ipamorelin selectively stimulates GH release without significantly affecting cortisol or prolactin levels in research models.
$65.00
In StockFor research purposes only. Not for human consumption.
Mechanism of Action
CJC-1295 acts at pituitary GHRH receptors to amplify and extend GH secretory pulses via cAMP/PKA signaling. Ipamorelin selectively binds the ghrelin receptor (GHS-R1a) to stimulate GH release independently of the GHRH pathway. When combined, the two peptides work through complementary mechanisms — GHRH-receptor and ghrelin-receptor activation — producing synergistic GH pulse amplitude in research models while maintaining selectivity over ACTH and cortisol pathways.
Research Focus Areas
- Growth hormone release support studies
- Increased IGF-1 production pathway research
- Synergistic GHRH/GHRP mechanism models
- Anti-aging and metabolic signaling research